Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

BlinkLab Halts Trading Ahead Of Shank2 Autism Study Results

Blinklab Limited (BB1) · Health care

BB1: $0.570 +0.00% · MC: $106M

BlinkLab Limited requested a trading halt pending the release of results from its Shank2 autism study. Trading is expected to resume when the results announcement is released or at the start of normal trading on Wednesday, whichever comes first.

Source announcements: 2026-11-09 09:28 to 2026-11-09 09:28 Sydney time
Story updated 2026-11-09 09:32 Sydney time
SourcesTrading Halt
Comments